IsoPlexis Corp
DelistedCIK 1615055fmd_1938C1XMW4ZB9V803712SMSBNZManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2020 to Dec 31, 2022, 12 periods
| Line item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Total revenues | 10 | 17 | 17 |
| Net interest income | (0) | (4) | (5) |
| Gross profit | 5 | 9 | (1) |
| Research and development | 11 | 21 | 24 |
| Selling, general and administrative | 22 | 64 | 73 |
| Total operating expenses | 33 | 85 | 100 |
| Operating income | (27) | (76) | (101) |
| Net income | (82) | (82) | (106) |
| Net income to common shareholders | (29) | (92) | (106) |